ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC to Bid On Ovarian Cancer Treatment RFP; Community MDs Handle 90% Of Ovarian Patients

September 5, 1975

NCI Grant Awards

October 8, 1993

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

NCAB Approves Plan for Public Participation Hearings Around U.S.

February 20, 1987

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

Revised Guidelines For Core, Exploratory Grants Available

March 5, 1976